Insilico Medicine raises $255m in Series C
Eight Roads has a strong credential in healthcare investment. It was the founding investor of Innovent Biologics, Hua Medicine, Adagene and Citrine Medicine. It also invested in Semma Therapeutics, Shouti and Insilico Medicine.